Cargando...

Naturally Occurring PCSK9 Inhibitors

Genetic, epidemiological and pharmacological data have led to the conclusion that antagonizing or inhibiting Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces cardiovascular events. This clinical outcome is mainly related to the pivotal role of PCSK9 in controlling low-density lipoprotei...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nutrients
Main Authors: Adorni, Maria Pia, Zimetti, Francesca, Lupo, Maria Giovanna, Ruscica, Massimiliano, Ferri, Nicola
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284437/
https://ncbi.nlm.nih.gov/pubmed/32429343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu12051440
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!